[{"address1": "6000 Shoreline Court", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 243 6300", "fax": "650 243 6388", "website": "https://www.veracyte.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 824, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marc A. Stapley", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1690500, "exercisedValue": 0, "unexercisedValue": 2219004}, {"maxAge": 1, "name": "Ms. Rebecca  Chambers", "age": 46, "title": "Executive VP & CFO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 970980, "exercisedValue": 0, "unexercisedValue": 1155266}, {"maxAge": 1, "name": "Dr. Phillip G. Febbo M.D.", "age": 58, "title": "Chief Scientific & Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1006750, "exercisedValue": 0, "unexercisedValue": 441723}, {"maxAge": 1, "name": "Ms. Annie  McGuire", "age": 44, "title": "Executive VP, General Counsel & Chief People Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 862210, "exercisedValue": 0, "unexercisedValue": 786969}, {"maxAge": 1, "name": "Dr. John  Leite Ph.D.", "age": 52, "title": "Global Chief Commercial Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 865313, "exercisedValue": 0, "unexercisedValue": 654582}, {"maxAge": 1, "name": "Dr. Keith  Gligorich Ph.D.", "title": "Senior Vice President of Global Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan  Wygant", "age": 53, "title": "VP & Chief Accounting Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven  French", "title": "Senior VP & Chief Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karen  Possemato", "title": "Senior Vice President of Corporate Marketing, Communications & Commercial Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Corinne  Danan", "title": "Senior Vice President", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 1, "compensationRisk": 5, "shareHolderRightsRisk": 4, "overallRisk": 3, "governanceEpochDate": 1751328000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 23.59, "open": 25.505, "dayLow": 24.8, "dayHigh": 26.11, "regularMarketPreviousClose": 23.59, "regularMarketOpen": 25.505, "regularMarketDayLow": 24.8, "regularMarketDayHigh": 26.11, "payoutRatio": 0.0, "beta": 2.073, "trailingPE": 60.11905, "forwardPE": 63.125, "volume": 5298101, "regularMarketVolume": 5298101, "averageVolume": 1091680, "averageVolume10days": 1365220, "averageDailyVolume10Day": 1365220, "bid": 18.72, "ask": 31.84, "bidSize": 2, "askSize": 2, "marketCap": 1977443712, "fiftyTwoWeekLow": 19.73, "fiftyTwoWeekHigh": 47.316, "priceToSalesTrailing12Months": 4.2673144, "fiftyDayAverage": 26.7088, "twoHundredDayAverage": 34.172825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1740589952, "profitMargins": 0.07132, "floatShares": 77871350, "sharesOutstanding": 78314600, "sharesShort": 6111924, "sharesShortPriorMonth": 5942060, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.078, "heldPercentInsiders": 0.00537, "heldPercentInstitutions": 1.07988, "shortRatio": 6.38, "shortPercentOfFloat": 0.0871, "impliedSharesOutstanding": 78314600, "bookValue": 15.26, "priceToBook": 1.6546527, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 33049000, "trailingEps": 0.42, "forwardEps": 0.4, "enterpriseToRevenue": 3.756, "enterpriseToEbitda": 27.948, "52WeekChange": 0.09639597, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 25.25, "targetHighPrice": 45.0, "targetLowPrice": 29.0, "targetMeanPrice": 40.33333, "targetMedianPrice": 42.0, "recommendationMean": 1.72727, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 287355008, "totalCashPerShare": 3.669, "ebitda": 62280000, "totalDebt": 50501000, "quickRatio": 4.541, "currentRatio": 5.1, "totalRevenue": 463392992, "debtToEquity": 4.226, "revenuePerShare": 5.995, "returnOnAssets": 0.0194, "returnOnEquity": 0.028570002, "grossProfits": 326407008, "freeCashflow": 76930376, "operatingCashflow": 89424000, "revenueGrowth": 0.182, "grossMargins": 0.70438004, "ebitdaMargins": 0.1344, "operatingMargins": 0.07032, "financialCurrency": "USD", "symbol": "VCYT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NGM", "messageBoardId": "finmb_42154124", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1753485389, "regularMarketTime": 1753473601, "shortName": "Veracyte, Inc.", "longName": "Veracyte, Inc.", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1091680, "fiftyTwoWeekLowChange": 5.5200005, "fiftyTwoWeekLowChangePercent": 0.27977702, "fiftyTwoWeekRange": "19.73 - 47.316", "fiftyTwoWeekHighChange": -22.066002, "fiftyTwoWeekHighChangePercent": -0.4663539, "fiftyTwoWeekChangePercent": 9.639597, "earningsTimestamp": 1746648301, "earningsTimestampStart": 1754424000, "earningsTimestampEnd": 1754424000, "earningsCallTimestampStart": 1754512200, "earningsCallTimestampEnd": 1754512200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.42, "epsForward": 0.4, "epsCurrentYear": 1.30034, "priceEpsCurrentYear": 19.417997, "fiftyDayAverageChange": -1.4587994, "fiftyDayAverageChangePercent": -0.05461868, "twoHundredDayAverageChange": -8.922825, "twoHundredDayAverageChangePercent": -0.2611088, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "marketState": "CLOSED", "regularMarketChangePercent": 7.03688, "regularMarketPrice": 25.25, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1383139800000, "postMarketChangePercent": 0.39604113, "postMarketPrice": 25.35, "postMarketChange": 0.10000038, "regularMarketChange": 1.66, "regularMarketDayRange": "24.8 - 26.11", "displayName": "Veracyte", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]